RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of approval for the manufacture of specified cell processed products, namely the Accreditation Certificate of Foreign Cell Processor from Mr. Takemi Keizou, Minister of Health, Labour and Welfare in Japan. This prestigious certification highlights our commitment to excellence in cell processing and our adherence to the highest standards in biomedical research and manufacturing.
This latest certification complements RGCC’s long-standing accreditations, which include certifications from the International Accreditation Service (IAS), TÜV Austria, the College of American Pathologists (CAP), the National Organization for Medicines (EOF) in Greece, as well as the Certificate of GMP Compliance.
“We are honored to receive this certification from Japan’s Ministry of Health, Labour and Welfare,” said Dr. Ioannis Papasotiriou, CEO of RGCC. “This recognition underscores our dedication to maintaining the highest standards of quality and safety in regenerative medicine. It also reaffirms our commitment to supporting global biomedical research and advancing innovative treatments.”
RGCC has been at the forefront of biomedical research for over 20 years, providing cutting-edge services and products that support the development of personalized medicine and therapies. Our laboratory's extensive accreditations demonstrate our continuous commitment to ensuring the highest quality and safety of our processes and products.